ID   OP-9S/LMJSN
AC   CVCL_HC58
DR   Wikidata; Q54936440
RX   Patent=US9121008;
RX   PubMed=15650053;
CC   Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.
CC   Doubling time: 58-72 hours (PubMed=15650053).
CC   Transfected with: MGI; MGI:1098270; Jag2.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HC57 ! OP-9S
SX   Sex unspecified
AG   Embryo
CA   Stromal cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
RX   Patent=US9121008;
RA   Tsai S.;
RT   "Development of natural killer cells and functional natural killer
RT   cell lines.";
RL   Patent number US9121008, 01-Sep-2015.
//
RX   PubMed=15650053; DOI=10.1182/blood-2004-11-4237;
RA   DeHart S.L., Heikens M.J., Tsai S.;
RT   "Jagged2 promotes the development of natural killer cells and the
RT   establishment of functional natural killer cell lines.";
RL   Blood 105:3521-3527(2005).
//